Search

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?

Collaboration and thoughtful automation at scale will be critical for unlocking cell and gene therapies for patients

Sitting Down With Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania.

What does the future hold for Tregs? Treg-cell therapy could transform the way we treat autoimmune disease and transplant rejection.

Contribute to our special feature celebrating the future of pharma.

Cell and Gene therapies have come a long way since the 1970s. Technology, combined with knowledge, will take them even further.

How metabolic conditioning could improve cell therapy potency and persistence.

What was described by a University of California professor as gene therapy's "single most remarkable achievement?"

This issue marks The Medicine Maker's third birthday!

A step closer to an off-the-shelf CAR T cell therapy.